Biomaterials: Core Growth Enabler in the Rising Incidence Of Cardiovascular Diseases Boosts Biomaterials Market Market, 2025

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Will the Biomaterials Industry Market Size Be by 2025?
The biomaterials industry has seen a swift expansion in its market size in recent years. The market is projected to climb from $134.31 billion in 2024 to $153.55 billion in 2025, advancing at a compound annual growth rate (CAGR) of 14.3%. The historic growth can be linked to factors such as an increasing elderly population, the integration of biomaterials into orthopedics and dentistry, heightened consciousness about environmental sustainability, higher occurrence of chronic conditions in medicine, and an escalated demand for medical implants.

What's the Long-Term Growth Forecast for the Biomaterials Market Size Through 2029?
Anticipated to see accelerated growth in the coming years, the biomaterials market is projected to reach a staggering $262.56 billion in 2029, boasting a compound annual growth rate (CAGR) of 14.4%. The burgeoning growth over the forecast period can be credited to evolving consumer trends, a significant surge in the requirement for biomaterials in 3d printing and additive manufacturing along with the expansion of the biodegradable and bioresorbable biomaterials sector. Inclusion of biomaterials in personalized medicine drug delivery systems and their increasing employment in wound care and tissue regeneration also contribute to this market growth. Key trends set to dominate the forecast period are the production of intelligent biomaterials with adaptive and responsive characteristics, the inclusion of nanotechnology for amplified functionality, a focus on precision medicine resulting in tailor-made biomaterial solutions, the exploration of biomaterial sources drawn from marine and plant life, and strategic alliances between biomaterial corporations and medical institutions for inventive applications.

View the full report here:
https://www.thebusinessresearchcompany.com/report/biomaterials-global-market-report

What Are the Key Growth Drivers Fueling the Biomaterials Market Expansion?
The escalating number of cases of cardiovascular complications is fueling the expansion of the biomaterials industry. High blood pressure, smoking, high cholesterol, lack of physical activity and other causes lead to cardiovascular diseases. Non-communicable illnesses such as diabetes, chronic pulmonary diseases, coronary artery disease (CAD) and hypertension-induced heart attacks are primary reasons for the growth in prevalence of these cardiovascular disorders. Biomaterials including heart valves, heart-lung machines, stents, vascular grafts, total artificial hearts, and pacemakers serve as restorative instruments for injured or diseased heart tissue. For example, data from the Centers for Disease Control and Prevention, a public agency based in the US, showed that in May 2023, coronary artery disease (CAD) was the culprit behind 375,476 fatalities in 2021, and roughly 1 in 20 adults aged 20 and above were affected by CAD. Furthermore, nearly 2 out of 10 fatalities due to CAD occurred in adults under 65. Hence, the surge in the occurrence of cardiovascular diseases is anticipated to elevate the necessity for the biomaterials industry.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6808&type=smp

What Are the Key Trends Driving Biomaterials Market Growth?
A significant trend becoming prevalent in the biomaterials market is strategic collaborations. Key players in the market are honing in on forming partnerships to invent new implants and combination devices that are based on biomaterials, using each other's skills, technologies, and assets. These alliances focus on boosting the acceptance of biomaterials, which allows them to gain an edge over their competitors and amplify their revenues. Take, for instance, the US-based corporation IFF, which unveiled a Designed Enzymatic Biomaterials (DEB) technology platform in June 2023, aimed to fulfill the rising demand for sustainable, high-performance materials. This technology facilitates exact drug delivery by deploying engineered enzymes to activate therapeutic components in reaction to targeted biological signals. It also significantly impacts tissue engineering, where enzyme reactions aid tissue restoration by fostering cell growth and orchestrating scaffolding degradation at designated rates. This DEB technology helps customize biobased polysaccharides to parallel or surpass the effectiveness of conventional petroleum-based polymers, ultimately boosting their market adoption.

How Is the Biomaterials Market Segmented?
The biomaterials market covered in this report is segmented -

1) By Type: Metallic Biomaterial, Polymeric Biomaterials, Natural Biomaterials, Ceramics
2) By Application: Cardiovascular, Orthopedic, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Neurological/Central Nervous System
3) By End Use: Hospitals And Clinics, Ambulatory Surgical Centers, Other End Users

Subsegments:
1) By Metallic Biomaterials: Stainless Steel, Titanium Alloys, Cobalt-Chromium Alloys, Magnesium Alloys
2) By Polymeric Biomaterials: Synthetic Polymers, Natural Polymers, Biodegradable Polymers
3) By Natural Biomaterials: Animal-Derived Materials, Plant-Derived Materials
4) By Ceramics: Bioceramics, Porous Ceramics, Non-porous Ceramics

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=6808&type=smp

Which Companies Are Leading the Charge in Biomaterials Market Innovation?
Major companies operating in the biomaterials market include Corbion N V, Evonik Industries AG, Heraeus Medical Components LLC, Berkeley Advanced Biomaterials Inc., Zimmer Biomet Holdings Inc., DSM Biomedical BV, PolyNovo Limited, Baxter International Inc., Stryker Corporation, Collagen Solutions plc, Invibio Ltd., Aap Implantate AG, Cam Bioceramics BV, CeramTec GmbH, CoorsTek Medical LLC, CryoLife Inc., Cerapedics Inc., Surmodics Inc., Secant Group LLC, GELITA AG, Quattroflow GmbH, Kyocera Corporation, Wright Medical Group NV, KLS Martin Group GmbH & Co KG, Meccellis Biotechnology Co Ltd., Bio-on SpA, Coloplast A/S, Collagen Matrix Inc., IntrinsiQ Materials Inc., PolyActiva Pty Ltd

Which Regions Are Leading the Global Biomaterials Market in Revenue?
North America was the largest region in the biomaterials market in 2024. The regions covered in the biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6808

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.